A5070928171- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Acute Ischemic Stroke Management
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Acute Myocardial Infarction Research
- Stroke Rehabilitation and Recovery
- Cardiac Arrhythmias and Treatments
- Diabetes Treatment and Management
- Potassium and Related Disorders
- Venous Thromboembolism Diagnosis and Management
- Blood Pressure and Hypertension Studies
- Medication Adherence and Compliance
- Cardiac Health and Mental Health
- Mechanical Circulatory Support Devices
- Antiplatelet Therapy and Cardiovascular Diseases
- Healthcare Policy and Management
- Cardiac electrophysiology and arrhythmias
- Cardiac, Anesthesia and Surgical Outcomes
- Lipoproteins and Cardiovascular Health
- Pharmaceutical Practices and Patient Outcomes
- Cardiac Imaging and Diagnostics
- Cardiac Arrest and Resuscitation
- Cardiac Structural Anomalies and Repair
University of California, Los Angeles
2016-2025
Ronald Reagan UCLA Medical Center
2016-2025
UCLA Medical Center
2016-2025
Los Angeles Medical Center
2016-2025
UCLA Health
2016-2025
Twitter (United States)
2019-2025
Duke University
2013-2024
Massachusetts General Hospital
2014-2024
Clinical Research Institute
2014-2024
Emory University
2008-2024
Background— Heart failure (HF) is an important contributor to both the burden and cost of national healthcare expenditures, with more older Americans hospitalized for HF than any other medical condition. With aging population, impact expected increase substantially. Methods Results— We estimated future costs by adapting a methodology developed American Association project epidemiology from 2012 2030 without double counting attributed comorbid conditions. The model assumes that prevalence...
HomeCirculationVol. 113, No. 19AHA/ACC Guidelines for Secondary Prevention Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
EART FAILURE CAUSES CONsiderable morbidity and mortality is responsible for a tremendous burden on the health care system in United States. 1 It accounted approximately million hospital discharges 2001, an increase of 164% since 1979, associated with overall annual cost nearly $29 billion. Reported in-hospital ranges from as low 2.3% among patients enrolled clinical trials to 19% referral series. 2,3espite this dramatic public hospitalization heart failure, models risk stratification during...
Nesiritide is approved in the United States for early relief of dyspnea patients with acute heart failure. Previous meta-analyses have raised questions regarding renal toxicity and mortality associated this agent.We randomly assigned 7141 who were hospitalized failure to receive either nesiritide or placebo 24 168 hours addition standard care. Coprimary end points change at 6 hours, as measured on a 7-point Likert scale, composite point rehospitalization death within 30 days.Patients...
Readmission after hospitalization for heart failure is common. Early outpatient follow-up has been proposed as a means of reducing readmission rates. However, there are limited data describing patterns and its association with rates.To examine associations between within 7 days discharge from 30 days.Observational analysis patients 65 years or older discharged to home hospitals participating in the Organized Program Initiate Lifesaving Treatment Hospitalized Patients With Heart Failure Get...
The association between systolic blood pressure (SBP) at admission, clinical characteristics, and outcomes in patients hospitalized for heart failure who have reduced or relatively preserved function has not been well studied.To evaluate the relationship SBP profile, acute failure.Cohort study using data from Organized Program to Initiate Lifesaving Treatment Hospitalized Patients with Heart Failure (OPTIMIZE-HF) registry performance-improvement program 259 US hospitals March 2003 December...
◼ angioedema angiotensin-converting enzyme inhibitors angiotensin receptor blockers